Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Sable Therapeutics Announces Licensing Agreement with Shanghai Liuqiang Medical Technology
Sable Therapeutics, an early-stage biotechnology company developing novel therapies for fat reduction, today announced that […]
Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology
Aldena Therapeutics, a private biotech company pioneering siRNA-based therapies for dermatological indications, and Empa, the […]
Huma and UCB to Provide Digital Health Solution for Myasthenia Gravis
Huma Therapeutics, a leading global digital health company, and UCB, a global biopharmaceutical company, are […]
RQM+ Appoints Steven Pilewski as Lab Services Chief Operating Officer
RQM+, the world’s leading MedTech service provider, has announced the appointment of Steven Pilewski as […]
Mezzion Pharma Raises Nearly $40M to Advance a First-to-Market Treatment Option for Fontan Patients
Mezzion Pharma, a rare disease-focused pharmaceutical company, announced that it has secured nearly $40M USD […]
Ciliatech Raises €3.5M in Series A Funding
Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, […]
I-Mab Announces Positive Outcome in Arbitration Relating to Agreements with Tracon
I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, […]
Adcentrx Therapeutics Announces Completion of $38 million Series A+ Financing Led by Eight Roads Ventures
Adcentrx Therapeutics, a biotechnology company dedicated to revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer and […]
ImmunoGen Appoints Isabel Kalofonos as Senior Vice President and Chief Commercial Officer
ImmunoGen, a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of […]
Strand Therapeutics Appoints Colleen Wilson as Chief People Officer
Strand Therapeutics, the programmable mRNA company developing curative therapies for cancer and other diseases, today […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more